These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19301115)

  • 1. Responding to her question: a review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in sub-Saharan Africa.
    MacCarthy S; Laher F; Nduna M; Farlane L; Kaida A
    AIDS Behav; 2009 Jun; 13 Suppl 1():66-71. PubMed ID: 19301115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
    J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good news for women living with HIV.
    Anastos K
    J Infect Dis; 2007 Oct; 196(7):971-3. PubMed ID: 17763315
    [No Abstract]   [Full Text] [Related]  

  • 5. Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review.
    Ferguson L; Grant AD; Watson-Jones D; Kahawita T; Ong'ech JO; Ross DA
    Trop Med Int Health; 2012 May; 17(5):564-80. PubMed ID: 22394050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of highly active antiretroviral therapy on obstetric conditions: A review.
    Sebitloane HM; Moodley D
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():126-131. PubMed ID: 28013100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and virologic response to antiretroviral therapy in South Africa.
    Westreich D; Cole SR; Nagar S; Maskew M; van der Horst C; Sanne I
    PLoS One; 2011; 6(8):e22778. PubMed ID: 21829650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
    Colombini M; Stöckl H; Watts C; Zimmerman C; Agamasu E; Mayhew SH
    AIDS Care; 2014; 26(7):914-26. PubMed ID: 24354642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras.
    Prins M; Meyer L; Hessol NA
    AIDS; 2005 Mar; 19(4):357-70. PubMed ID: 15750389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prevention before HAART in sub-Saharan Africa.
    Marseille E; Hofmann PB; Kahn JG
    Lancet; 2002 May; 359(9320):1851-6. PubMed ID: 12044394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents.
    Uneke CJ; Ogbonna A
    Trans R Soc Trop Med Hyg; 2009 Aug; 103(8):761-7. PubMed ID: 18707747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.
    Shapiro RL; Ndung'u T; Lockman S; Smeaton LM; Thior I; Wester C; Stevens L; Sebetso G; Gaseitsiwe S; Peter T; Essex M
    J Infect Dis; 2005 Sep; 192(5):713-9. PubMed ID: 16088820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.